SAB Biotherapeutics to Present at the Ladenburg Thalmann Annual Healthcare Conference 2021 Jul 9, 2021 07:00AM
SAB Biotherapeutics to List on Nasdaq through Merger with Big Cypress Acquisition (BCYP) Jun 22, 2021 06:23AM
SAB Biotherapeutics to List on Nasdaq through Merger with Big Cypress Acquisition Corp., Advancing Unique Human Antibody Platform with Demonstrated Utility in Immunotherapy and Rapid Response to Emerg Jun 22, 2021 06:00AM
Big Cypress Acquisition Corp. Announces Separate Trading of its Shares of Common Stock and Redeemable Warrants Commencing February 9, 2021 Feb 4, 2021 08:00AM
Big Cypress Acquisition Corp. Announces Closing of $115 Million Initial Public Offering, which Includes Full Exercise of the Underwriters' Over-Allotment Option Jan 14, 2021 12:10PM


Jan 11, 2021 04:25PM Big Cypress Acquisition Corp. (BCYP) Prices 10M Unit IPO at $10/Unit
Jan 11, 2021 04:23PM Big Cypress Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering